Clavulanate lithium
Modify Date: 2024-01-02 09:09:57
Clavulanate lithium structure
|
Common Name | Clavulanate lithium | ||
|---|---|---|---|---|
| CAS Number | 61177-44-4 | Molecular Weight | 205.09400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C8H8LiNO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Symbol |
GHS08 |
Signal Word | Danger | |
Use of Clavulanate lithiumClavulanate lithium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2]. |
| Name | lithium clavulanate |
|---|---|
| Synonym | More Synonyms |
| Description | Clavulanate lithium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2]. |
|---|---|
| Related Catalog | |
| Target |
β-lactamase[1] |
| In Vitro | Clavulanate lithium has weak antibacterial activity against most organisms when administered alone, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase[1]. Clavulanate lithium (0.25, 0.5 mg/L) causes a relatively slow inhibition of growth, and a higher concentration (1 mg/L) is only marginally more effective than 0.5 mg/L [2]. Cell Viability Assay[2] Cell Line: L. pneumophila NCTC 1119 Concentration: 0.25 mg/L, 0.5 mg/L, 1 mg/L Incubation Time: 0-35 hours Result: Caused a relatively slow inhibition of growth. |
| References |
| Molecular Formula | C8H8LiNO5 |
|---|---|
| Molecular Weight | 205.09400 |
| Exact Mass | 205.05600 |
| PSA | 89.90000 |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H360 |
| Precautionary Statements | P201-P280-P308 + P313 |
| Hazard Codes | Xn |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| CLAVULANIC ACID LITHIUM SALT |
| Clavulanate Lithium |
| CLAVULANATE LITHIUM SALT, ANTIBIOTIC FOR CULTURE MEDIA USE ONLY |